Here’s a key Social Security issue that Elon Musk’s DOGE task force could tackle — and it’s not fraud
Overpayments can be both costly to the government and to the beneficiaries who face aggressive efforts to claw back the funds, often years after they’ve received them ...
Le Lézard23h
U.S. FDA Accepts Gilead's New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir?the company's twice-yearly injectable HIV ...